Pascal and Francis Bibliographic Databases

Help

Permanent link : http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19153084

Export

Selection :

Intravenous methoxy polyethylene glycol-epoetin beta for haemoglobin control in patients with chronic kidney disease who are on dialysis : a randomised non-inferiority trial (MAXIMA). Commentery

Author
WALKER, Rowan G (Commentator (written text)) 1 2 ; STRIPPOLI, Giovanni F. M (Commentator (written text)) 3 4 ; OGUEY, Delphine12 ; LEVIN, Nathan W5 ; FISHBONE, Steven6 ; CANEDO, Francisco Valdés7 ; ZEIG, Steven8 ; NASSAR, George M9 ; MORAN, John E10 ; VILLA, Giuseppe11 ; BEYER, Ulrich12
[1] North West Dialysis, Royal Melbourne Hospital, Melbourne, VIC, Australia
[2] Department of Epidemiology and Preventive Medicine, Monash University Alfred Hospital, Melbourne VIC, Australia
[3] Cochrane Renal Group, School of Public Health, University of Sydney, Sydney, NSW, Australia
[4] Mario Negri Sud Consortium, Chieti, Italy
[5] Renal Research Institute, New York, NY, United States
[6] Winthrop University Hospital, Mineola, NY, United States
[7] Hospital Juan Canalejo, La Coruña, Spain
[8] Pines Clinical Research Inc, Pembroke Pines, FL, United States
[9] Rénal Research Inc, Houston, TX, United States
[10] Satellite Healthcare Inc, Mountain View, CA, United States
[11] Fondazione 'S Maugeri', IRCCS, Pavia, Italy
[12] F Hoffmann-La Roche Ltd, Basel, Switzerland
MAXIMA study investigators
Source

Lancet (British edition). 2007, Vol 370, Num 9596 ; 1395-1396, 1415-1421 [9 p.] ; ref : 35 ref

CODEN
LANCAO
ISSN
0140-6736
Scientific domain
General medicine general surgery
Publisher
Lancet, London
Publication country
United Kingdom
Document type
Article
Language
English
Keyword (fr)
Antianémique Contrôle Dialyse Epoétine bêta Essai clinique Ethylène oxyde polymère Homme Hémoglobine Malade Médecine Randomisation Surveillance Voie intraveineuse Néphropathie chronique Appareil urinaire pathologie Insuffisance rénale Rein pathologie
Keyword (en)
Antianemia agent Check Dialysis Epoetin beta Clinical trial Ethylene oxide polymer Human Hemoglobin Patient Medicine Randomization Surveillance Intravenous administration Chronic kidney disease Urinary system disease Renal failure Kidney disease
Keyword (es)
Agente antianémico Control Diálisis Epoetina beta Ensayo clínico Etileno óxido polímero Hombre Hemoglobina Enfermo Medicina Aleatorización Vigilancia Vía intravenosa Nefropatía crónica Aparato urinario patología Insuficiencia renal Riñón patología
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B01 General aspects

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B14 Nephrology. Urinary tract diseases / 002B14A Nephropathies. Renovascular diseases. Renal failure / 002B14A05 Renal failure

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B14 Nephrology. Urinary tract diseases / 002B14E Urinary system involvement in other diseases. Miscellaneous / 002B14E01 Kidneys

Discipline
Generalities in medical sciences Nephrology. Urinary tract diseases
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
19153084

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Searching the Web